Bonn University supports research staff in stem cell furore
This article was originally published in Clinica
The University of Bonn has dismissed criticism of two members of its staff, Professor Otmar Wiestler and Dr Oliver Brustle, who had voiced the hope of being able to import embryonic stem cells for research purposes (see Clinica No 962, p 5). In a public debate last week, the board of the faculty of medicine acknowledged that a factual discussion on research into both adult and embryonic stem cells was a necessity, but that personal attacks on its staff members were "unwarranted and discriminatory".
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.